Background A research priority for Plasmodium vivax malaria is to improve our understanding of the spatial distribution of risk and its relationship with the burden of P. vivax disease in human populations. The aim of the research outlined in this article is to provide a contemporary evidence-based map of the global spatial extent of P. vivax malaria, together with estimates of the human population at risk (PAR) of any level of transmission in 2009. Methodology The most recent P. vivax case-reporting data that could be obtained for all malaria endemic countries were used to classify risk into three classes: malaria free, unstable (<0.1 case per 1,000 people per annum (p.a.)) and stable (≥0.1 case per 1,000 p.a.) P. vivax malaria transmission. Risk areas were further constrained using temperature and aridity data based upon their relationship with parasite and vector bionomics. Medical intelligence was used to refine the spatial extent of risk in specific areas where transmission was reported to be absent (e.g., large urban areas and malaria-free islands). The PAR under each level of transmission was then derived by combining the categorical risk map with a high resolution population surface adjusted to 2009. The exclusion of large Duffy negative populations in Africa from the PAR totals was achieved using independent modelling of the gene frequency of this genetic trait. It was estimated that 2.85 billion people were exposed to some risk of P. vivax transmission in 2009, with 57.1% of them living in areas of unstable transmission. The vast majority (2.59 billion, 91.0%) were located in Central and South East (CSE) Asia, whilst the remainder were located in America (0.16 billion, 5.5%) and in the Africa+ region (0.10 billion, 3.5%). Despite evidence of ubiquitous risk of P. vivax infection in Africa, the very high prevalence of Duffy negativity throughout Central and West Africa reduced the PAR estimates substantially. Conclusions After more than a century of development and control, P. vivax remains more widely distributed than P. falciparum and is a potential cause of morbidity and mortality amongst the 2.85 billion people living at risk of infection, the majority of whom are in the tropical belt of CSE Asia. The probability of infection is reduced massively across Africa by the frequency of the Duffy negative trait, but transmission does occur on the continent and is a concern for Duffy positive locals and travellers. The final map provides the spatial limits on which the endemicity of P. vivax transmission can be mapped to support future
References
[1]
Snow RW, Craig MH, Newton CRJC, Steketee RW (2003) The public health burden of Plasmodium falciparum malaria in Africa: deriving the numbers. Working Paper No. 11. Bethesda, Maryland, U.S.A.: Disease Control Priorities Project, Fogarty International Center, National Institutes of Health.
[2]
Hay SI, Guerra CA, Tatem A, Atkinson P, Snow RW (2005) Urbanization, malaria transmission and disease burden in Africa. Nat Rev Microbiol 3: 81–90. doi: 10.1038/nrmicro1069
[3]
Mendis K, Sina BJ, Marchesini P, Carter R (2001) The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97–106.
[4]
Baird JK (2007) Neglect of Plasmodium vivax malaria. Trends Parasitol 23: 533–539. doi: 10.1016/j.pt.2007.08.011
[5]
Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, et al. (2007) Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77: 79–87.
[6]
Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, et al. (2009) Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 9: 555–566. doi: 10.1016/S1473-3099(09)70177-X
[7]
Guerra CA, Snow RW, Hay SI (2006) Defining the global spatial limits of malaria transmission in 2005. Adv Parasitol 62: 157–179. doi: 10.1016/S0065-308X(05)62005-2
[8]
Guerra CA, Snow RW, Hay SI (2006) Mapping the global extent of malaria in 2005. Trends Parasitol 22: 353–358. doi: 10.1016/j.pt.2006.06.006
[9]
Sattabongkot J, Tsuboi T, Zollner GE, Sirichaisinthop J, Cui L (2004) Plasmodium vivax transmission: chances for control? Trends Parasitol 20: 192–198. doi: 10.1016/j.pt.2004.02.001
[10]
Baird JK (2009) Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev 22: 508–534. doi: 10.1128/CMR.00008-09
[11]
Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, et al. (2008) Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 5: e127. doi: 10.1371/journal.pmed.0050127
[12]
Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, et al. (2008) Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 5: e128. doi: 10.1371/journal.pmed.0050128
[13]
Anstey NM, Russell B, Yeo TW, Price RN (2009) The pathophysiology of vivax malaria. Trends Parasitol 25: 220–227. doi: 10.1016/j.pt.2009.02.003
[14]
Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, et al. (2009) Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg 80: 194–198.
[15]
Barcus MJ, Basri H, Picarima H, Manyakori C, Sekartuti , et al. (2007) Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg 77: 984–991.
[16]
Parakh A, Agarwal N, Aggarwal A, Aneja A (2009) Plasmodium vivax malaria in children: uncommon manifestations. Ann Trop Paediatr 29: 253–256. doi: 10.1179/027249309X12547917868844
[17]
Hay SI, Snow RW (2006) The Malaria Atlas Project: Developing global maps of malaria risk. PLoS Med 3: e473. doi: 10.1371/journal.pmed.0030473
[18]
Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, et al. (2008) The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med 5: e38. doi: 10.1371/journal.pmed.0050038
[19]
Hay SI, Guerra CA, Gething PW, Patil AP, Tatem AJ, et al. (2009) A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 6: e48. doi: 10.1371/journal.pmed.1000048
[20]
Snow RW, Guerra CA, Mutheu JJ, Hay SI (2008) International funding for malaria control in relation to populations at risk of stable Plasmodium falciparum transmission. PLoS Med 5: e142. doi: 10.1371/journal.pmed.0050142
[21]
Gething PW, Patil AP, Hay SI (2010) Quantifying aggregated uncertainty in Plasmodium falciparum malaria prevalence and populations at risk via efficient space-time geostatistical joint simulation. PLoS Comput Biol 6: e1000724. doi: 10.1371/journal.pcbi.1000724
[22]
Hay SI, Okiro EA, Gething PW, Patil AP, Tatem AJ, et al. (2010) Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med. in press. doi: 10.1371/journal.pmed.1000290
[23]
Feachem R, Sabot O (2008) A new global malaria eradication strategy. Lancet 371: 1633–1635. doi: 10.1016/S0140-6736(08)60424-9
[24]
Roll Back Malaria Partnership (2008) The Global Malaria Action Plan: For a malaria-free world.
[25]
Centers for Disease Control and Prevention (2009) CDC Health Information for International Travel 2010. Atlanta: U.S. Department of Health and Human Services, Public Health Service.
[26]
WHO (2010) International Travel and Health: Situation as on 1 January 2010. Geneva: World Health Organization.
[27]
FAO (2008) The Global Administrative Unit Layers (GAUL): Technical Aspects. Rome: Food and Agriculture Organization of the United Nations, EC-FAO Food Security Programme (ESTG).
[28]
Pampana E (1969) A textbook of malaria eradication. London: Oxford University Press.
[29]
Hay SI, Smith DL, Snow RW (2008) Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis 8: 369–378. doi: 10.1016/S1473-3099(08)70069-0
[30]
Yekutiel P (1980) III The Global Malaria Eradication Campaign. In: Klingberg MA, editor. Eradication of infectious diseases: a critical study. Basel, Switzerland: Karger. pp. 34–88.
[31]
Nikolaev BP (1935) On the influence of temperature on the development of malaria plasmodia inside the mosquito. Leningrad Pasteur Institute of Epidemiology and Bacteriology.
[32]
Hijmans RJ, Cameron SE, Parra JL, Jones PG, Jarvis A (2005) Very high resolution interpolated climate surfaces for global land areas. Int J Climatol 25: 1965–1978. doi: 10.1002/joc.1276
[33]
Kiszewski A, Mellinger A, Spielman A, Malaney P, Sachs SE, et al. (2004) A global index representing the stability of malaria transmission. Am J Trop Med Hyg 70: 486–498.
[34]
Shililu JI, Grueber WB, Mbogo CM, Githure JI, Riddiford LM, et al. (2004) Development and survival of Anopheles gambiae eggs in drying soil: influence of the rate of drying, egg age, and soil type. J Am Mosq Control Assoc 20: 243–247.
[35]
Gray EM, Bradley TJ (2005) Physiology of desiccation resistance in Anopheles gambiae and Anopheles arabiensis. Am J Trop Med Hyg 73: 553–559.
Omer SM, Cloudsley-Thompson JL (1970) Survival of female Anopheles gambiae Giles through a 9-month dry season in Sudan. Bull World Health Organ 42: 319–330.
[38]
Omer SM, Cloudsley-Thomson JL (1968) Dry season biology of Anopheles gambiae Giles in the Sudan. Nature 217: 879–880.
[39]
Bouma MJ, Parvez SD, Nesbit R, Winkler AM (1996) Malaria control using permethrin applied to tents of nomadic Afghan refugees in northern Pakistan. Bull World Health Organ 74: 413–421.
[40]
Balk DL, Deichmann U, Yetman G, Pozzi F, Hay SI, et al. (2006) Determining global population distribution: methods, applications and data. Adv Parasitol 62: 119–156. doi: 10.1016/S0065-308X(05)62004-0
[41]
Hay SI, Sinka ME, Okara RM, Kabaria CW, Mbithi PM, et al. (2010) Developing maps of the dominant Anopheles vectors of human malaria. PLoS Med 7: e1000209. doi: 10.1371/journal.pmed.1000209
[42]
Miller LH, Mason SJ, Clyde DF, McGinniss MH (1976) The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295: 302–304. doi: 10.1056/NEJM197608052950602
[43]
Mourant AE, Kopec AC, Domaniewska-Sobczak K (1976) The Distribution of the Human Blood Groups and other Polymorphisms. London: Oxford University Press.
[44]
Cavalli-Sforza LL, Menozzi P, Piazza A (1994) The History and Geography of Human Genes. Princeton, New Jersey: Princeton University Press.
[45]
Cutbush M, Mollison PL (1950) The Duffy blood group system. Heredity 4: 383–389. doi: 10.1038/hdy.1950.31
[46]
Langhi DM Jr, Bordin JO (2006) Duffy blood group and malaria. Hematology 11: 389–398. doi: 10.1080/10245330500469841
[47]
UNPD (2008) World Urbanization Prospects: The 2007 Revision Population Database. http://esa.un.org/unpp/. December 2009.
[48]
Hay SI, Noor AM, Nelson A, Tatem AJ (2005) The accuracy of human population maps for public health application. Trop Med Int Health 10: 1073–1086. doi: 10.1111/j.1365-3156.2005.01487.x
[49]
Ministério da Saúde de Cabo VerdeDirec？？o Geral de SaúdePrograma Nacional de Luta Contra o Paludismo (2009) Plano Estratégico de Pré-Elimina？？o do Paludismo 2009–2013.
[50]
PAHO (2006) Regional Strategic Plan for Malaria in the Americas 2006–2010. Washington DC: Pan American Health Organization.
Tchen J, Ouledi A, Lepere JF, Ferrandiz D, Yvin JL (2006) Epidemiologie et prevention du paludisme dans les iles du sud-ouest de l'Ocean Indien. Med Trop (Mars) 66: 295–301.
[53]
Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, et al. (2000) Malaria eradication on islands. Lancet 356: 1560–1564. doi: 10.1016/S0140-6736(00)03127-5
[54]
EMRO (2008) Technical discussion on malaria elimination in the Eastern Mediterranean Region: vision, requirements and strategic outline. World Health Organization Regional Office for the Eastern Mediterranean.
[55]
Zhang W, Wang L, Fang L, Ma J, Xu Y, et al. (2008) Spatial analysis of malaria in Anhui province, China. Malar J 7: 206. doi: 10.1186/1475-2875-7-206
[56]
Coatney GR, Collins WE, Warren M, Contacos PG (2003) The primate malarias.[CD-ROM; original book published 1971]. Atlanta, Georgia, USA: Centers for Disease Control and Prevention.
[57]
Garnham PCC (1988) Malaria parasites of man: life-cycles and morphology (excluding ultrastructure). In: Wernsdorfer WH, McGregor I, editors. Malaria: principles and practice of malariology. Edinburgh: Churchill Livingstone. pp. 61–96.
[58]
Welch SG, McGregor IA, Williams K (1977) The Duffy blood group and malaria prevalence in Gambian West Africans. Trans R Soc Trop Med Hyg 71: 295–296. doi: 10.1016/0035-9203(77)90102-X
[59]
Mathews HM, Armstrong JC (1981) Duffy blood types and vivax malaria in Ethiopia. Am J Trop Med Hyg 30: 299–303.
[60]
Rosenberg R (2007) Plasmodium vivax in Africa: hidden in plain sight? Trends Parasitol 23: 193–196. doi: 10.1016/j.pt.2007.02.009
[61]
Cavasini CE, Mattos LC, Couto AA, Bonini-Domingos CR, Valencia SH, et al. (2007) Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception? Trans R Soc Trop Med Hyg 101: 1042–1044. doi: 10.1016/j.trstmh.2007.04.011
[62]
Ryan JR, Stoute JA, Amon J, Dunton RF, Mtalib R, et al. (2006) Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. Am J Trop Med Hyg 75: 575–581.
[63]
Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, et al. (2010) Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci U S A 107: 5967–5971. doi: 10.1073/pnas.0912496107
[64]
Collins WE, Roberts JM (1991) Anopheles gambiae as a host for geographic isolates of Plasmodium vivax. J Am Mosq Control Assoc 7: 569–573.
[65]
Taye A, Hadis M, Adugna N, Tilahun D, Wirtz RA (2006) Biting behavior and Plasmodium infection rates of Anopheles arabiensis from Sille, Ethiopia. Acta Trop 97: 50–54. doi: 10.1016/j.actatropica.2005.08.002
[66]
Mayxay M, Pukrittayakamee S, Newton PN, White NJ (2004) Mixed-species malaria infections in humans. Trends Parasitol 20: 233–240. doi: 10.1016/j.pt.2004.03.006
[67]
Maitland K, Williams TN, Newbold CI (1997) Plasmodium vivax and P. falciparum: Biological interactions and the possibility of cross-species immunity. Parasitol Today 13: 227–231. doi: 10.1016/S0169-4758(97)01061-2
[68]
Gautret P, Legros F, Koulmann P, Rodier MH, Jacquemin JL (2001) Imported Plasmodium vivax malaria in France: geographical origin and report of an atypical case acquired in Central or Western Africa. Acta Trop 78: 177–181. doi: 10.1016/S0001-706X(00)00181-9
Durante Mangoni E, Severini C, Menegon M, Romi R, Ruggiero G, et al. (2003) Case report: An unusual late relapse of Plasmodium vivax malaria. Am J Trop Med Hyg 68: 159–160.
Culleton R, Ndounga M, Zeyrek FY, Coban C, Casimiro PN, et al. (2009) Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central Africa. J Infect Dis 200: 1465–1469. doi: 10.1086/644510
[81]
Comellini L, Tozzola A, Baldi F, Brusa S, Serra L, et al. (1998) Plasmodium vivax congenital malaria in a newborn of a Zairian immigrant. Ann Trop Paediatr 18: 41–43.
[82]
Rubio JM, Benito A, Roche J, Berzosa PJ, Garcia ML, et al. (1999) Semi-nested, multiplex polymerase chain reaction for detection of human malaria parasites and evidence of Plasmodium vivax infection in Equatorial Guinea. Am J Trop Med Hyg 60: 183–187.
[83]
Peruzzi S, Gorrini C, Piccolo G, Calderaro A, Dettori G, et al. (2007) Prevalence of imported malaria in Parma during 2005–2006. Acta Biomed 78: 170–175.
[84]
Sintasath DM, Ghebremeskel T, Lynch M, Kleinau E, Bretas G, et al. (2005) Malaria prevalence and associated risk factors in Eritrea. Am J Trop Med Hyg 72: 682–687.
[85]
Teka H, Petros B, Yamuah L, Tesfaye G, Elhassan I, et al. (2008) Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia. Malar J 7: 220. doi: 10.1186/1475-2875-7-220
[86]
Poirriez J, Landau I, Verhaeghe A, Savage A, Dei-Cas E (1991) [Atypical forms of Plasmodium vivax. Apropos of a case]. Ann Parasitol Hum Comp 66: 149–154.
[87]
Rabarijaona LP, Randrianarivelojosia M, Raharimalala LA, Ratsimbasoa A, Randriamanantena A, et al. (2009) Longitudinal survey of malaria morbidity over 10 years in Saharevo (Madagascar): further lessons for strengthening malaria control. Malar J 8: 190. doi: 10.1186/1475-2875-8-190
[88]
Cortes H, Morillas-Marquez F, Valero A (2003) Malaria in Mauritania: the first cases of malaria endemic to Nouakchott. Trop Med Int Health 8: 297–300. doi: 10.1046/j.1365-3156.2003.01029.x
[89]
Lekweiry KM, Abdallahi MO, Ba H, Arnathau C, Durand P, et al. (2009) Preliminary study of malaria incidence in Nouakchott, Mauritania. Malar J 8: 92. doi: 10.1186/1475-2875-8-92
[90]
Wejda BU, Huchzermeyer H, Dormann AJ (2002) Hotel malaria in Greece: Mozambique origin, American vector, German victims. J Travel Med 9: 277. doi: 10.2310/7060.2002.24113
[91]
Erhabor O, Babatunde S, Uko KE (2006) Some haematological parameters in plasmodial parasitized HIV-infected Nigerians. Niger J Med 15: 52–55. doi: 10.4314/njm.v15i1.37116
[92]
Snounou G, Pinheiro L, Antunes AM, Ferreira C, do Rosario VE (1998) Non-immune patients in the Democratic Republic of Sao Tome e Principe reveal a high level of transmission of P. ovale and P. vivax despite low frequency in immune patients. Acta Trop 70: 197–203. doi: 10.1016/S0001-706X(98)00021-7
[93]
Peragallo MS, Sabatinelli G, Majori G, Cali G, Sarnicola G (1997) Prevention and morbidity of malaria in non-immune subjects; a case-control study among Italian troops in Somalia and Mozambique, 1992–1994. Trans R Soc Trop Med Hyg 91: 343–346. doi: 10.1016/S0035-9203(97)90101-2
[94]
Himeidan YE, Elbashir MI, El-Rayah el A, Adam I (2005) Epidemiology of malaria in New Halfa, an irrigated area in eastern Sudan. East Mediterr Health J 11: 499–504.
[95]
Illamperuma C, Allen BL (2007) Pulmonary edema due to Plasmodium vivax malaria in an American missionary. Infection 35: 374–376. doi: 10.1007/s15010-007-6108-x
[96]
Blossom DB, King CH, Armitage KB (2005) Occult Plasmodium vivax infection diagnosed by a polymerase chain reaction-based detection system: a case report. Am J Trop Med Hyg 73: 188–190.
